CA2003213A1 - Azolylmethylcarbinols cyclopropyl substitues ayant une activite antimycotique - Google Patents

Azolylmethylcarbinols cyclopropyl substitues ayant une activite antimycotique

Info

Publication number
CA2003213A1
CA2003213A1 CA2003213A CA2003213A CA2003213A1 CA 2003213 A1 CA2003213 A1 CA 2003213A1 CA 2003213 A CA2003213 A CA 2003213A CA 2003213 A CA2003213 A CA 2003213A CA 2003213 A1 CA2003213 A1 CA 2003213A1
Authority
CA
Canada
Prior art keywords
cyclopropyl
antimycotically active
azolylmethylcarbinols
substituted
active cyclopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2003213A
Other languages
English (en)
Other versions
CA2003213C (fr
Inventor
Klaus Stroech
Karl Heinz Buchel
Burkhard Fugmann
Manfred Plempel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of CA2003213A1 publication Critical patent/CA2003213A1/fr
Application granted granted Critical
Publication of CA2003213C publication Critical patent/CA2003213C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002003213A 1988-11-19 1989-11-17 Azolylmethylcarbinols cyclopropyl substitues ayant une activite antimycotique Expired - Fee Related CA2003213C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3839170.8 1988-11-19
DE3839170A DE3839170A1 (de) 1988-11-19 1988-11-19 Cyclopropyl-substituierte azolylmethylcarbinole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
CA2003213A1 true CA2003213A1 (fr) 1990-05-19
CA2003213C CA2003213C (fr) 1999-08-03

Family

ID=6367500

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002003213A Expired - Fee Related CA2003213C (fr) 1988-11-19 1989-11-17 Azolylmethylcarbinols cyclopropyl substitues ayant une activite antimycotique

Country Status (9)

Country Link
US (1) US5059615A (fr)
EP (1) EP0370300B1 (fr)
JP (1) JP2839161B2 (fr)
KR (1) KR0128662B1 (fr)
AT (1) ATE103907T1 (fr)
CA (1) CA2003213C (fr)
DE (2) DE3839170A1 (fr)
ES (1) ES2052863T3 (fr)
ZA (1) ZA898775B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4206529A1 (de) * 1992-03-02 1993-09-09 Bayer Ag Azolylmethyl-cyclopropyl-derivate
CN106632107A (zh) * 2012-12-19 2017-05-10 巴斯夫欧洲公司 取代[1,2,4]三唑及其作为杀真菌剂的用途
AR100743A1 (es) * 2014-06-06 2016-10-26 Basf Se Compuestos de [1,2,4]triazol sustituido
TW201617310A (zh) * 2014-07-18 2016-05-16 拜耳作物科學公司 作為用於抵抗非生物性植物逆境之活性成分的經取代之乙烯基－及炔基－氰基環烷醇與乙烯基－及炔基－氰基雜環烷醇
AR101214A1 (es) 2014-07-22 2016-11-30 Bayer Cropscience Ag Ciano-cicloalquilpenta-2,4-dienos, ciano-cicloalquilpent-2-en-4-inas, ciano-heterociclilpenta-2,4-dienos y ciano-heterociclilpent-2-en-4-inas sustituidos como principios activos contra el estrés abiótico de plantas
WO2016116555A1 (fr) 2015-01-22 2016-07-28 Sanofi-Aventis Deutschland Gmbh Procédé pour la production de 2-[4-(cyclopropanecarbonyl)phényl]-2-méthyl-propanenitrile
TWI637948B (zh) * 2015-11-17 2018-10-11 維愛美製藥公司 製備４－（（６－（２－（２，４－二氟苯基）－１，１－二氟－２－羥基－３－（１ｈ－１，２，４－三唑－１－基）丙基）吡啶－３－基）氧基）苄腈之方法
JP6898340B2 (ja) * 2015-11-17 2021-07-07 コルテバ アグリサイエンス エルエルシー ４−（（６−（２−（２，４−ジフルオロフェニル）−１，１−ジフルオロ−２−ヒドロキシ−３−（１ｈ−１，２，４−トリアゾール−１−イル）プロピル）ピリジン−３−イル）オキシ）ベンゾニトリル及び調製方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0106515B1 (fr) * 1982-09-30 1988-12-28 Pfizer Limited Dérivés du triazole comme agents antifongiques
EP0180850A3 (fr) * 1984-11-02 1987-05-27 Bayer Ag Dérivés d'azolylméthyl-cyclopropyl-carbinols antimycotiques
US4859232A (en) * 1986-12-05 1989-08-22 Monsanto Company Substituted-aryl cyclopropanecarbonitriles and derivatives thereof as herbicide antidotes
DE3732385A1 (de) * 1987-09-25 1989-04-06 Bayer Ag Hydroxyalkylcyclopropyl1-1,2,4-triazolyl- oder -imidazolyl-derivate und ihre verwendung als antimykotische mittel
JP2681648B2 (ja) * 1988-03-29 1997-11-26 富山化学工業株式会社 新規な２−アゾリル−１−シクロプロピルエタノール誘導体およびその塩

Also Published As

Publication number Publication date
DE3839170A1 (de) 1990-05-31
ATE103907T1 (de) 1994-04-15
KR0128662B1 (ko) 1998-04-04
EP0370300B1 (fr) 1994-04-06
CA2003213C (fr) 1999-08-03
DE58907399D1 (de) 1994-05-11
ES2052863T3 (es) 1994-07-16
KR900007816A (ko) 1990-06-02
US5059615A (en) 1991-10-22
JP2839161B2 (ja) 1998-12-16
EP0370300A3 (fr) 1991-07-03
JPH02243673A (ja) 1990-09-27
ZA898775B (en) 1990-08-29
EP0370300A2 (fr) 1990-05-30

Similar Documents

Publication Publication Date Title
AU6884687A (en) Indolizine derivatives, process for preparing them and the compositions containing them
IE893712L (en) Quinuclidines, their use as medicaments and processes for¹their preparation
AU7702291A (en) Dietary fiber, its process and physiologically active composition containing the same as an active ingredient
AU3091489A (en) Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
GR3014958T3 (en) 2,4- and 2,5-Pyridine-dicarboxylic-acid derivatives, process for their preparation, their use and medicines based on these compounds.
HUT61554A (en) Process for producing 2,8-dioxabicyclo/3.2.1/octane derivatives and pharmaceutical compositions comprising same
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
AU8315287A (en) New alkanesulfonanilide and alkylaminosulfonanilide derivatives, processes for their preparation and pharmaceutical compositions comprising the same
AU3732889A (en) Substituted allylamine derivatives, process for their preparation and their use
AU2861389A (en) Disubstituted pyridines
CA2003213A1 (fr) Azolylmethylcarbinols cyclopropyl substitues ayant une activite antimycotique
AU622010B2 (en) Substituted 1,8-naphthyridines
AU578916B2 (en) Milbemycin derivative, process for the preparation thereof, and use thereof in pest control
AU2457688A (en) New fluoromethoxyphenyl dihydropyridines, processes for the preparation and their use in medicaments
AU585207B2 (en) Hydantoin derivatives, process for producing the same and medicine containing the same.
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
AU664101B2 (en) Novel phospholipid derivatives
EP0246861A3 (en) Pharmaceutical composition based on crotoxine, process for preparing the active component and the pharmaceutical composition
IL89401A0 (en) Medicaments containing 1,4-dihydropyridine derivatives for the treatment of alcohol addiction
ES8607016A1 (es) Preparado solido de nifedipina
AU8082687A (en) 2,6-diamino-3-halobenzylpyridines and processes for their manufacture as well as their use in pharmaceuticals
AU647608B2 (en) Isoxazolylimidazole derivatives, process for their production and their use in pharmaceutical agents
EP0583698A3 (fr) Dérivés du déoxy-cyclitol, procédé pour leur préparation et leur utilisation dans des médicaments.
GR1002048B (en) Phenilacetic acid derivatives, process for the preparation thereof and corresponding use.
AU1119892A (en) Physiologically active kanglemycin c, process for preparing the same and use thereof

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed